SEARCH

SEARCH BY CITATION

References

  • Arima K., Uéda K., Sunohara N., Arakawa K., Hirai S., Nakamura M., Tonozuka-Uehara H. & Kawai M. (1998) NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. (Berlin) 96, 439444.
  • Baba M., Nakajo S., Tu P. H., Tomita T., Nakaya K., Lee V. M., Trojanowski J. Q. & Iwatsubo T. (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879884.
  • Ben-Shlomo Y., Wenning G. K., Tison F. & Quinn N. P. (1997) Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 48, 384393.
  • Campbell B. C., Li Q. X., Culvenor J. G., Jakala P., Cappai R., Beyreuther K., Masters C. L. & McLean C. A. (2000) Accumulation of insoluble α-synuclein in dementia with Lewy bodies. Neurobiol. Dis. 7, 192200.
  • Culvenor J. G., McLean C. A., Cutt S., Campbell B. C., Maher F., Jäkälä P., Hartmann T., Beyreuther K., Masters C. L. & Li Q. X. (1999) Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited: NAC and α-synuclein are not associated with Aβ amyloid. Am. J. Pathol. 155, 11731181.
  • Dickson D. W. (1999) Tau and synuclein and their role in neuropathology. Brain Pathol. 9, 657661.
  • Dickson D. W., Liu W., Hardy J., Farrer M., Mehta N., Uitti R., Mark M., Zimmerman T., Golbe L., Sage J., Sima A., D'amato C., Albin R., Gilman S. & Yen S. (1999) Widespread alterations of α-synuclein in multiple system atrophy. Am. J. Pathol. 155, 12411251.
  • El-Agnaf O. M., Jakes R., Curran M. D., Middleton D., Ingenito R., Bianchi E., Pessi A., Neill D. & Wallace A. (1998) Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett. 440, 7175.DOI: 10.1016/s0014-5793(98)01418-5
  • Gilman S., Low P. A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C. J., Kaufmann H., Klockgether T., Lang A. E., Lantos P. L., Litvan I., Mathias C. J., Oliver E., Robertson D., Schatz I. & Wenning G. K. (1999) Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci. 163, 9498.DOI: 10.1016/s0022-510x(98)00304-9
  • Hashimoto M. & Masliah E. (1999) α-synuclein in Lewy body disease and Alzheimer's disease. Brain Pathol. 9, 707720.
  • Irizarry M. C., Growdon W., Gomez-Isla T., Newell K., George J. M., Clayton D. F. & Hyman B. T. (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol. 57, 334337.
  • Jakes R., Spillantini M. G. & Goedert M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 2732.
  • Koo E. H., Lansbury P. T. Jr & Kelly J. W. (1999) Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl Acad. Sci. USA 96, 99899990.DOI: 10.1073/pnas.96.18.9989
  • Krüger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L. & Riess O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106108.
  • Lavedan C. (1998) The synuclein family. Genome Res. 8, 871880.DOI: 10.1101/gr.8.9.871
  • Li Q. X., Maynard C., Cappai R., McLean C. A., Cherny R. A., Lynch T., Culvenor J. G., Trevaskis J., Tanner J. E., Bailey K. A., Czech C., Bush A. I., Beyreuther K. & Masters C. L. (1999) Intracellular accumulation of detergent-soluble amyloidogenic Aβ fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice. J. Neurochem. 72, 24792487.
  • Lue L. F., Kuo Y. M., Roher A. E., Brachova L., Shen Y., Sue L., Beach T., Kurth J. H., Rydel R. E. & Rogers J. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853862.
  • Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L. & Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 42454249.
  • Matsuo A., Akiguchi I., Lee G. C., McGeer E. G., McGeer P. L. & Kimura J. (1998) Myelin degeneration in multiple system atrophy detected by unique antibodies. Am. J. Pathol. 153, 735744.
  • McKeith I. G., Galasko D., Kosaka K., Perry E. K., Dickson D. W., Hansen L. A., Salmon D. P., Lowe J., Mirra S. S., Byrne E. J., Lennox G., Quinn N. P., Edwardson J. A., Ince P. G., Bergeron C., Burns A., Miller B. L., Lovestone S., Collerton D., Jansen E. N., Ballard C., De Vos R. A., Wilcock G. K., Jellinger K. A. & Perry R. H. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 11131124.
  • McLean C. A., Cherny R. A., Fraser F. W., Fuller S. J., Smith M. J., Beyreuther K., Bush A. I. & Masters C. L. (1999) Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860866.
  • Morton R. E. & Evans T. A. (1992) Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein protein content. Anal. Biochem. 204, 332334.
  • Olichney J. M., Galasko D., Salmon D. P., Hofstetter C. R., Hansen L. A., Katzman R. & Thal L. J. (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 51, 351357.
  • Ostrerova N., Petrucelli L., Farrer M., Mehta N., Choi P., Hardy J. & Wolozin B. (1999) α-Synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 19, 57825791.
  • Petratos S., Turnbull V. J., Papadopoulos R., Ayers M. & Gonzales M. F. (1998) Antibodies against peripheral myelin glycolipids in people with HIV infection. Immunol. Cell Biol. 76, 535541.
  • Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I. & Nussbaum R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 20452047.DOI: 10.1126/science.276.5321.2045
  • Prusiner S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136144.
  • Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. & Goedert M. (1997) α-synuclein in Lewy bodies. Nature 388, 839840.
  • Spillantini M. G., Crowther R. A., Jakes R., Cairns N. J., Lantos P. L. & Goedert M. (1998) Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 251, 205208.DOI: 10.1016/s0304-3940(98)00504-7
  • Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L. & Masliah E. (1998) Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am. J. Pathol. 152, 367372.
  • Tompkins M. M. & Hill W. D. (1997) Contribution of somal Lewy bodies to neuronal death. Brain Res. 775, 2429.DOI: 10.1016/s0006-8993(97)00874-3
  • Trojanowski J. Q. & Lee V. M. (1998) Aggregation of neurofilament and α-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch. Neurol. 55, 151152.
  • Tu P. H., Galvin J. E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J. Q. & Lee V. M. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann. Neurol. 44, 415422.
  • Wakabayashi K., Matsumoto K., Takayama K., Yoshimoto M. & Takahashi H. (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci. Lett. 239, 4548.DOI: 10.1016/s0304-3940(97)00891-4
  • Wakabayashi K., Hayashi S., Kakita A., Yamada M., Toyoshima Y., Yoshimoto M. & Takahashi H. (1998) Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. (Berlin) 96, 445452.
  • Wood S. J., Wypych J., Steavenson S., Louis J. C., Citron M. & Biere A. L. (1999) Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J. Biol. Chem. 274, 1950919512.